IFP Advisors
IMCR icon

IFP Advisors’s Immunocore IMCR Stock Holding History

IFP Advisors’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-2,749
Closed -$87.3K – 5320
2026
Q2 		$87.3K Hold
2,749
– – ﹤0.01% 2066
2026
Q1 		$82.9K Hold
2,749
– – ﹤0.01% 1966
2025
Q4 		$95.4K Sell
2,749
-27
-1% -$953 ﹤0.01% 1825
2025
Q3 		$101K Sell
2,776
-6
-0.2% -$204 ﹤0.01% 1673
2025
Q2 		$87.3K Sell
2,782
-16
-0.6% -$497 ﹤0.01% 1712
2025
Q1 		$83K Sell
2,798
-136
-5% -$4.08K ﹤0.01% 1633
2024
Q4 		$86.6K Buy
2,934
+96
+3% +$3.04K ﹤0.01% 1543
2024
Q3 		$88.3K Sell
2,838
-197
-6% -$7.16K ﹤0.01% 1463
2024
Q2 		$103K Sell
3,035
-27
-0.9% -$1.38K ﹤0.01% 1357
2024
Q1 		$199K Sell
3,062
-17
-0.6% -$1.17K 0.01% 1003
2023
Q4 		$210K Buy
3,079
+682
+28% +$35.4K 0.01% 926
2023
Q3 		$124K Buy
2,397
+594
+33% +$35.2K 0.01% 1161
2023
Q2 		$108K Buy
1,803
+1,703
+1,703% +$97.2K ﹤0.01% 1283
2023
Q1 		$4.32K Hold
100
– – ﹤0.01% 2628
2022
Q4 		$4K Buy
+100
New +$5.63K ﹤0.01% 3900

Other funds holding IMCR

Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
Fulcrum Asset Management
Fulcrum Asset Management London, United Kingdom $2.14B AUM 54.66% 1-Year Est. Return

IFP Advisors's IMCR Position: Q3 2026 in Review

IFP Advisors sold out of Immunocore (IMCR) in Q3 2026, closing a stake of 2,749 shares — an estimated $87.3K sold.

IFP Advisors first reported a position in IMCR in Q4 2022 and held it in 15 quarters. The position peaked at $210K in Q4 2023. 55 funds tracked by Wall St. Rank hold IMCR as of Q3 2026.

  • IFP Advisors reported no remaining Immunocore position as of Q3 2026 after selling out during the quarter.
  • IFP Advisors sold 2,749 Immunocore shares in Q3 2026, an estimated $87.3K.
  • IFP Advisors first reported a position in Immunocore in Q4 2022 and held it in 15 quarters.
  • IFP Advisors's Immunocore position peaked at $210K in Q4 2023.
  • 55 funds tracked by Wall St. Rank held Immunocore as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.